Effects of Kinesio Taping on Hip Abductor Muscle Strength and EMG Activity

NCT ID: NCT04728672

Last Updated: 2021-01-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-12-12

Study Completion Date

2020-12-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Athletes with chronic ankle instability tend to develop Glutei muscle weakness. This weakness makes the lower limb prone to injuries. Kinesio Tape (KT) may assist this muscle in performing its functions thus preventing injuries.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim was to study the effects of Kinesio Tape on hip abductor muscle strength and EMG activity. Pretest-posttest experimental design was used. The study was conducted in the research lab of the University. Thirty-four athletes with a mean age of 22.08 years participated in the study. For the experimental group Kinesio Tape and for the control group Micropore Tape (MT) was applied over Gluteus Medius (GM) muscle. GM muscle's strength and EMG activity were noted in supine and during the Single-Leg Squat Test (SLST) respectively before and after the intervention. Hip abductor muscle strength measured through a maximum voluntary isometric contraction (MVIC) and GM activation measured through EMG. Handheld dynamometer (Lafayette manual muscle test system), Power Lab EMG system.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Ankle Instability

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Two parallel groups pretest-posttest design.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental Group

Kinesio tape was applied and then outcome measures were noted.

Group Type EXPERIMENTAL

Kinesio Tape

Intervention Type OTHER

Kinesio Tape

Control Group

Placebo Micropore Tape was applied and then outcome measures were noted.

Group Type PLACEBO_COMPARATOR

Micropore Tape

Intervention Type OTHER

Micropore Tape

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Kinesio Tape

Kinesio Tape

Intervention Type OTHER

Micropore Tape

Micropore Tape

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Repeated episodes of giving way after an initial ankle sprain,
* A history of at least 2 ankle sprains to the same side without injury to the contralateral ankle in the last 2 years,
* No history of other trauma to the lower extremities for the past 3 months prior to the study,
* Participants also needed to be capable of full weight-bearing without analgia,
* Subjectively reported that functional use of ankle had plateaued since the last injury.

Exclusion Criteria

* Participants having a history of ankle fracture, knee ligament injury, back or lower limb surgery, neuromuscular disease, or current neurological deficit,
* Currently receiving ankle rehabilitation were excluded from the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

26 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

King Saud University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Masood Khan

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Masood Khan, MPTh

Role: PRINCIPAL_INVESTIGATOR

King Saud University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

King Saud University

Riyadh, , Saudi Arabia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Saudi Arabia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RRC-2019-27

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.